Neuralink first received US Food and Drug Administration (FDA) approval to conduct human trials in May 2023.
Bitcoin miner CleanSpark swung to a profit, easily cleared quarterly forecasts as bitcoin prices rally. Bitcoin snaps four-day losing streak.